Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
45.85    0.05 (0.11%)
Bid:
45.60
Ask:
45.90
Spread: 0.30 (0.658%)
Market Cap: £290.17m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

COVID-19 Update re: Noteholder Consent Request

11 Nov 2020 08:10

RNS Number : 9658E
Marston's PLC
11 November 2020
Ā 

Ā 

Ā 

11 November 2020

MARSTON'S PLC

("Marston's" or "the Group")

Ā 

COVID-19 Update re: Noteholder Consent Request

Ā 

As previously announced in May this year, the Group received overwhelming support from its bondholders for certain waivers and amendments for 2020 within its Secured Estate, due to the Government's mandate to temporarily close pubs and restaurants across the UK from 20 March to 4 July 2020 in response to the COVID-19 pandemic.

As we guided in our trading update on 15 October, Marston's outperformed the market in the 13 weeks to 3 October. The Group was able to successfully reopen approximately 99% of its pubs, albeit under varying degrees of trading restrictions. Encouragingly, like for like sales at the Group's managed and franchised pubs were 90% of the previous financial year during the corresponding period and during August, like for like sales increased 6%, illustrating the Group's ability to reopen and trade its pubs well in spite of the continued restrictions imposed on the hospitality sector. Cash generation was also ahead of expectations.

Marston's announces today that it has formally asked the holders of its Secured Class A Notes for a limited number of further technical waivers during the first half of 2021, as a precautionary measure following the renewed lockdown restrictions introduced in Wales on 23 October, and in England last week. The waivers being requested are required solely as a consequence of the enforced temporary re-closure of its pubs in England by the UK Government as a result of the COVID--19 pandemic measures, together with the continued uncertainty with regard to further potential lockdowns over the winter months. Noteholders have been asked to respond by 1 December and a meeting is scheduled forĀ 3 December 2020.

The financial and liquidity position of Marston's and its subsidiaries remains strong. As previously announced, the Group did not need to utilise the additional £70 million bank facility secured in May. In addition, the sale of Marston's Beer company to the joint venture with Carlsberg UK Holdings Limited completed in October, generating initial net proceeds of around £230 million, further reducing the Group's bank debt.

However, given the prevailing uncertain outlook, management are continuing to take a prudent approach and therefore believe it is appropriate to seek the waivers requested to provide the Security Group with maximum flexibility over the coming months should that be required.

In addition, and as previously announced, to further ensure that liquidity is maximised within theĀ Security Group, it has agreed not to make any distributions to the wider Marston's Group until afterĀ 2 October 2021Ā at the earliest.

Ā 

ENQUIRIES:

Marston's PLC Tel: 01902 329516

Instinctif Partners Tel: 020 7457 2010/2005

Ralph Findlay, Chief Executive Officer

Justine Warren

Andrew Andrea, Chief Financial and Corporate Development Officer

Matthew Smallwood

Ā 

NOTES TO EDITORS

Ā· Marston's is a leading pub operator with a 40% holding in Carlsberg Marston's Beer Company

Ā· It has an estate of 1,379 pubs situated nationally, comprising managed, franchised and leased pubs.

Ā 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
MSCEAPFFFENEFEA
Date   Source Headline
1st Jun 20262:38 pmRNSTotal Voting Rights
19th May 202611:12 amRNSDirector Declaration
12th May 20267:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 28 MARCH 2026
1st Apr 20263:12 pmRNSTotal Voting Rights
2nd Mar 202611:43 amRNSTotal Voting Rights
23rd Feb 20265:33 pmRNSHolding(s) in Company
11th Feb 202611:21 amRNSDirector/PDMR Shareholding
2nd Feb 20263:28 pmRNSTotal Voting Rights
28th Jan 202612:37 pmRNSResult of AGM
28th Jan 20267:00 amRNSTrading update for the 17 weeks to 24 January 2026
12th Jan 20262:00 pmRNSBlock listing Interim Review
9th Jan 20269:30 amRNSPurchase of shares into the EBT
2nd Jan 20262:55 pmRNSTotal Voting Rights
29th Dec 202510:46 amRNSDirector/PDMR Shareholding
29th Dec 202510:46 amRNSDirector/PDMR Shareholding
29th Dec 202510:44 amRNSDirector/PDMR Shareholding
29th Dec 202510:44 amRNSDirector/PDMR Shareholding
12th Dec 202511:07 amRNSAnnual Financial Report
11th Dec 20259:54 amRNSPurchase of shares into the EBT
1st Dec 20254:15 pmRNSTotal Voting Rights
28th Nov 202512:36 pmRNSDirector/PDMR Shareholding
28th Nov 202512:30 pmRNSDirector/PDMR Shareholding
25th Nov 20257:00 amRNSPRELIMINARY RESULTS
28th Oct 20254:54 pmRNSHolding(s) in Company
8th Oct 20257:00 amRNSTrading Update for 52 weeks to 27 September 2025
1st Oct 20254:16 pmRNSTotal Voting Rights
1st Sep 20253:22 pmRNSTotal Voting Rights
1st Aug 20254:17 pmRNSTotal Voting Rights
22nd Jul 20257:00 amRNSTrading Update for the 41 weeks to 12 July 2025
9th Jul 20252:35 pmRNSBlock listing Interim Review
1st Jul 20255:03 pmRNSTotal Voting Rights
26th Jun 20257:05 amRNSAppointment of Chief Financial Officer
13th May 20257:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 29 MARCH 2025
1st May 20253:04 pmRNSTotal Voting Rights
1st Apr 20251:40 pmRNSTotal Voting Rights
20th Mar 202512:48 pmRNSPurchase of shares into the EBT
17th Mar 20251:10 pmRNSPurchase of shares into the EBT
4th Mar 20257:00 amRNSDirectorate Change
25th Feb 20259:24 amRNSHolding(s) in Company
21st Jan 20253:21 pmRNSResult of AGM
21st Jan 20257:00 amRNSTrading Update for the 16 weeks to 18 January 2025
13th Jan 20253:36 pmRNSPurchase of shares into the EBT
10th Jan 202510:13 amRNSBlock listing Interim Review
8th Jan 202511:55 amRNSHolding(s) in Company
2nd Jan 202511:27 amRNSTotal Voting Rights
23rd Dec 202412:15 pmRNSDirector/PDMR Shareholding
20th Dec 202410:47 amRNSPurchase of shares into the EBT
17th Dec 20244:22 pmRNSAnnual Financial Report
12th Dec 20242:59 pmRNSDirector/PDMR Shareholding
6th Dec 20249:51 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.